Lv1
88 积分 2021-06-14 加入
Therapeutic experience of adult acute myeloid leukemia in a single institution of China and its relationship with chromosome karyotype
4小时前
待确认
Homoharringtonine-based induction regimens for patients with de-novo acute myeloid leukaemia: a multicentre, open-label, randomised, controlled phase 3 trial
4小时前
已完结
Quizartinib plus chemotherapy in newly diagnosed patients with FLT3-internal-tandem-duplication-positive acute myeloid leukaemia (QuANTUM-First): a randomised, double-blind, placebo-controlled, phase 3 trial
4小时前
已完结
Olverembatinib combined with venetoclax and reduced-intensity chemotherapy for adult newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia: a single-center, single-arm, phase 2 trial
7天前
已完结
The dynamic evolution of lineage switch under CD19 CAR-T treatment in non-KMT2A rearranged B-ALL patients
7天前
已完结
Venetoclax and ibrutinib induces durable clinical responses in marginal zone lymphoma
17天前
已完结
Postremission cytopenia management in patients with acute myeloid leukemia treated with venetoclax and azacitidine in VIALE-A
25天前
已完结
Outcomes of acute myeloid leukemia patients who responded to venetoclax and azacitidine and stopped treatment
25天前
已完结
Long-term survival with oral azacitidine for patients with acute myeloid leukemia in first remission after chemotherapy: Updated results from the randomized, placebo-controlled, phase 3 QUAZAR AML-001 trial
25天前
已完结
Survival outcomes in patients with acute myeloid leukaemia who received subsequent therapy for relapse in QUAZAR AML‐001
25天前
已完结
皖公网安备34019202002308
